United States S 64: Preserve Access to Affordable Generics and Biosimilars Act

Status: Introduced in Senate (as of 2019-01-09)

State: United States · Session: 116 · Bill: S 64

Subjects: Administrative law and regulatory procedures, Civil actions and liability, Competition and antitrust, Contracts and agency, Federal Trade Commission (FTC), Intellectual property, Judicial review and appeals, Licensing and registrations, Marketing and advertising, Prescription drugs

Sponsors: Amy Klobuchar, CHARLES ERNEST GRASSLEY, Chris Van Hollen, Joni Ernst, Kevin Cramer, PATRICK JOSEPH LEAHY, RICHARD J. DURBIN, SUSAN MARGARET COLLINS

View United States S 64 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.